The DOI matches its OpenAlex record; 23 of the 23 references it cites were found in a registry or an index.
The Prevalence of Metoclopramide-Induced Tardive Dyskinesia and Acute Extrapyramidal Movement Disorders
Abstract
BACKGROUND: Metoclopramide hydrochloride, a neuroleptic dopamine receptor antagonist used to treat gastric ailments, is reported to cause extrapyramidal movement disorders. The goals of this study were (1) to determine the prevalence and severity of tardive dyskinesia and acute extrapyramidal movement syndromes including akathisia, acute dystonia, and drug-induced parkinsonism in metoclopramide-treated patients and (2) to compare the prevalence and severity of tardive dyskinesia in metoclopramide-treated diabetics and nondiabetics. METHODS: From a list of metoclopramide-treated patients received from the Portland (Ore) Veterans Affairs Medical Center pharmacy, 53 patients met inclusion criteria and 51 (96%) agreed to participate. Controls consisted of a convenience sample drawn from the Portland Veterans Affairs Medical Center Outpatient Clinic who were matched to subjects on age (+/- 10 years), gender, and presence or absence of diabetes. Of 61 potential controls contacted, 51 (84%) agreed to participate. Metoclopramide-treated subjects and controls were seen by a rater who was "blind" to all diagnoses and treatments. The rater performed a standardized examination used to elicit signs and symptoms of tardive dyskinesia and acute extrapyramidal movement syndromes. RESULTS: The relative risk for tardive dyskinesia was 1.67 (95% confidence interval, 0.93 to 2.97), and the relative risk for drug-induced parkinsonism was 4.0 (95% confidence interval, 1.5 to 10.5). Metoclopramide-treated patients had significantly greater severity of tardive dyskinesia, drug-induced parkinsonism, and subjective akathisia than controls. Use of metoclopramide was associated with impairment in ambulation and increased use of benzodiazepines. Metoclopramide-treated diabetics had significantly greater severity of tardive dyskinesia than metoclopramide-treated nondiabetics. CONCLUSIONS: Metoclopramide use is associated with a significantly increased prevalence and severity of several extrapyramidal movement disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Statistical Methods for Rates and Proportions
Fleiss, J. L., Levin, B., & Paik, M. C. (2003) · Wiley Series in Probability and Statistics · doi:10.1002/0471445428 · Cited by 18,646
(1976) · Medical Entomology and Zoology · Cited by 8,899
Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences.
Tufte, E. R., Cohen, J., & Cohen, P. (1979) · Journal of the American Statistical Association · doi:10.2307/2286442 · Cited by 5,180
Arky, R. A. (1994) · Cited by 2,632
Research Diagnoses for Tardive Dyskinesia
Kane, J. M. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290040080014 · Cited by 937
Metoclopramide: An Updated Review of its Pharmacological Properties and Clinical Use
Harrington, R. A., Hamilton, C. W., Brogden, R. N., Linkewich, J. A., Romankiewicz, J. A., & Heel, R. C. (1983) · Drugs · doi:10.2165/00003495-198325050-00002 · Cited by 355
The Impact of Diabetes on the CNS
McCall, A. L. (1992) · Diabetes · doi:10.2337/diab.41.5.557 · Cited by 341
Clinical Epidemiology and Biostatistics
Kramer, M. S. (1988) · Springer eBooks · doi:10.1007/978-3-642-61372-2 · Cited by 330
Changes in Prevalence, Severity, and Recovery in Tardive Dyskinesia With Age
Smith, J. M. (1980) · Archives of General Psychiatry · doi:10.1001/archpsyc.1980.01780250054006 · Cited by 310
Metoclopramide: Pharmacology and clinical application
Bullard, D. E. (1983) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/0278-2391(83)90196-9 · Cited by 295
Prevalence of Parkinson's disease in the biracial population of Copiah County, Mississippi
Schoenberg, B. S., Anderson, D. W., & Haerer, A. F. (1985) · Neurology · doi:10.1212/wnl.35.6.841 · Cited by 247
Extrapyramidal reactions with metoclopramide.
Bateman, D. N., Rawlins, M. D., & Simpson, J. M. (1985) · BMJ · doi:10.1136/bmj.291.6500.930 · Cited by 226
Tardive Dyskinesia: A Task Force Report of the American Psychiatric Association
Greenberg, D. B. (1993) · Psychosomatics · doi:10.1016/s0033-3182(93)71896-4 · Cited by 222
Metoclopramide-induced movement disorders. Clinical findings with a review of the literature
Miller, L. G. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.11.2486 · Cited by 177
Clinical nonrecognition of neuroleptic-induced movement disorders: a cautionary study
Weiden, P. J., Mann, J. J., Haas, G. L., Mattson, M., & FRANCES, A. J. (1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.9.1148 · Cited by 147
Neuroleptic-induced akathisia: a review
Adler, L. A., Angrist, B., Reiter, S. R., & Rotrosen, J. (1989) · Psychopharmacology · doi:10.1007/bf00443404 · Cited by 131
Waddington, J. L. (1989) · International review of neurobiology · doi:10.1016/s0074-7742(08)60282-2 · Cited by 98
The Prevalence of Tardive Dyskinesia in Neuroleptic-Treated Diabetics
Ganzini, L. K. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810270071010 · Cited by 91
Self-citationExtrapyramidal Reactions to Metoclopramide and Prochlorperazine
Bateman, D. N., DARLING, W. M., Boys, R. J., & Rawlins, M. D. (1989) · QJM · doi:10.1093/oxfordjournals.qjmed.a068325 · Cited by 80
Tardive dyskinesia associated with metoclopramide.
Wiholm, B. ‐., Mortimer, Ö., Boëthius, G., & Häggström, J. E. (1984) · BMJ · doi:10.1136/bmj.288.6416.545 · Cited by 58
Casey, D. E. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-5-673_3 · Cited by 16
Cerebral Microvascular Transport and Metabolism: Implications for Diabetes
McCall, A. L. (1992) · Springer eBooks · doi:10.1007/978-1-4614-7524-8_5 · Cited by 11
Cited by
Updated Guidelines for the Diagnosis and Treatment of Gastroesophageal Reflux Disease
DeVault, K. R., & Castell, D. O. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41217.x · Cited by 1,130
Parkman, H. P., Hasler, W. L., & Fisher, R. S. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.055 · Cited by 738
Updated Guidelines for The Diagnosis and Treatment of Gastroesophageal Reflux Disease
DeVault, K. R., & Castell, D. O. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.1123_a.x · Cited by 544
Abell, T. L., Bernstein, V. K., Cutts, T., Farrugia, G., Forster, J., Hasler, W. L., Mccallum, R. W., Olden, K. W., Parkman, H. P., Parrish, C. R., et al. (2006) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00760.x · Cited by 361
ACG Clinical Guideline: Gastroparesis
Camilleri, M., Kuo, B., Nguyen, L., Vaughn, V. M., Petrey, J., Greer, K., Yadlapati, R., & Abell, T. L. (2022) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001874 · Cited by 332
Metadata
- Authors
- Ganzini, L. K.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association
- Published
- 1993-06-28
- Volume
- 153
- Issue
- 12
- Pages
- 1469-1469
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2011802448
- Cited by
- 269
- References
- 23
- FWCI
- 5.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.